The latest news for pharma industry insiders.
Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the breakout session at Trade & Channel Strategies in Philadelphia.
Ketamine intravenous treatment (KIT) may be more effective than traditional medication management for those with treatment resistant depression (TRD), helping reduce symptoms and improve responses to treatment, according to new a study published in the 2025 issue of
Entrepreneur Eliot Horowitz, who founded $22 billion database company MongoDB, is betting on artificial intelligence in the physical world.
Biocodex has partnered with Kinaxis® Inc. to modernize and optimize its processes. Through this collaboration, Biocodex aims to achieve greater forecast accuracy, simplify the management of regulatory challenges, and enhance resilience against disruptions.
Great article with good ideas for 2025!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
